Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Summary 
Osagie O. Imasogie is an entrepreneur and businessperson who founded 9 companies, among them: Phoenix IP Ventures LLC, Churchill Pharmaceuticals and Ilera Healthcare LLC and who has been at the head of 10 different companies. Presently, he holds the position of Chairman at Zelira Therapeutics Ltd., Chairman at Ilera Therapeutics LLC (a subsidiary of Zelira Therapeutics Ltd.), Chairman & Chief Executive Officer of Ibere Pharmaceuticals, Senior Managing Partner at Phoenix IP Ventures LLC (which he founded in 2010), Chairman of Ilera Healthcare LLC (which he founded in 2016) and Advisor at Ben Franklin Technology Partners. Osagie O. Imasogie is also Chairman for The University of Pennsylvania Law School, Attorney at Schnader Harrison Segal & Lewis LLP, Member of New York State Bar Association, Member of Wilson Council and Senior Managing Partner at Pipv Capital (he founded the company in 2004) and on the board of 8 other companies.

In his past career Mr. Imasogie was Chairman at Churchill Pharmaceuticals (he founded the company), EVP-Global Corporation Development at Dr. Reddy's Laboratories Ltd. and Chairman for Trigenesis Therapeutics, Inc. (a subsidiary of Dr. Reddy's Laboratories Ltd.), Founding Vice President at GSK Venture Fund, Chairman of iCeutica, Inc. (he founded the company), Chairman at Ception Therapeutics, Inc. (he founded the company in 2004), Chairman for Iroko Pharmaceuticals LLC (he founded the company), Partner-Corporate Finance at Pricewaterhouse & Co., VP & Director-Product Development Strategy at Smithkline Beckman Corp, VP, Director-Genetics & Discovery Venture at GlaxoSmithKline Research & Development, VP-International Sales & Marketing at DuPont Merck Pharmaceutical Co. and SVP-Business Development & General Counsel at Endo Pharmaceuticals, Inc. (he founded the company in 1997).

Mr. Imasogie received a graduate degree from London School of Economics & Political Science and a graduate degree from The University of Pennsylvania Law School.


Current positions of Osagie O. Imasogie 
NameTitle Since
FS KKR Capital Corp.
(Closed End Funds)
Independent Director 2019
FS KKR Capital Corp. II
(Investment Trusts)
Independent Director 2019
Ibere Pharmaceuticals
(Investment Holding Companies)
Chairman & Chief Executive Officer -
Zelira Therapeutics Limited
(Biotechnology & Medical Research)
Chairman 2019
Ilera Therapeutics LLC Chairman -
Ilera Healthcare LLC Chairman 2016
The University of Pennsylvania Law School Chairman -
Ben Franklin Technology Partners of Southeastern Pennsylvania Director -
Trustees of the University of Pennsylvania Trustee -
Beltraith Capital LLC Director -
The Philadelphia Museum of Art Director -
The Philadelphia Orchestra Association Director -
University of Pennsylvania Trustee -
Wilson Council Member -
New York State Bar Association Member -
Schnader Harrison Segal & Lewis LLP Attorney -
Pipv Capital Senior Managing Partner 2004
Phoenix IP Ventures LLC Co-Founder & Senior Managing Partner 2011
Ben Franklin Technology Partners /Ventures/ Advisor 2011


Holdings of Osagie O. Imasogie 
NameEquities%Valuation
FS KKR Capital Corp. (FSK)
(Closed End Funds)
48,4880.017%1,015,824 USD


Osagie O. Imasogie: Personal Network 
Most Read News 
05/20XAVIER NIEL : UWR shares spike as billionaire Xavier Niel discloses 27% stake
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/24ELON MUSK : In a faceoff with Elon Musk, the SEC blinked
RE
05/19ELON MUSK : Musk says 'Tesla is on my mind 24/7' amid concerns about Twitter distraction
RE
05/17ELON MUSK : Prominent hedge funds invested in Twitter before Musk unveiled plans
RE
05/25ELON MUSK : Twitter investors vote against re-electing Elon Musk ally to board
RE
05/27ELON MUSK : Musk sued by Twitter investors for stock 'manipulation' during takeover bid
RE
05/23HOCK TAN : Chipmaker Broadcom in talks to acquire VMware for $60 billion -sources
RE
05/17JPMorgan shareholders vote disapproval of CEO Dimon's special payout
RE
05/20LUCA DE MEO : Renault boss Luca de Meo could return to Japan in June - source
RE
More news


© 2022 People and Ownership :   
Osagie O. Imasogie : Connections